WHO ICTRP trial
Multi-center randomized double-blind controlled trial for Tangzhifang in the…
ChiCTR1800019413 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800019413 |
|---|---|
| Public title | Multi-center randomized double-blind controlled trial for Tangzhifang in the treatment of pre-diabetes |
| Scientific title | Standardized training of Chinese medicine for prevention and treatment of diabetes and development of Tangzhifang |
| Primary sponsor | Gansu Provincial Hospital of TCM |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | Pre-diabetes |
| Interventions | Group 1:Tangzhifang;Group 2:Placebo |
| Registration date | Nov 10, 2018 |
| Target size | Group 1:200;Group 2:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: